Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8146087rdf:typepubmed:Citationlld:pubmed
pubmed-article:8146087lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:8146087lifeskim:mentionsumls-concept:C0887965lld:lifeskim
pubmed-article:8146087lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:8146087pubmed:issue6lld:pubmed
pubmed-article:8146087pubmed:dateCreated1994-4-29lld:pubmed
pubmed-article:8146087pubmed:abstractTextMetastases from certain primary tumors frequently exhibit specific organ preference. Animal models have been developed to induce in a reproducible fashion the formation of organ-specific metastases by malignant melanoma cells. Some of these models rely on the use of immunodeficient mice, which can support the growth of murine as well as human malignant melanomas. Moreover, immunodeficient mice, because of their diminished ability to mount an effective immune response, allow the expression of malignant properties (e.g., preferential colonization of certain organs), which are intrinsic to transplanted melanoma cells. This review discusses the relevant factors (and limitations) of some of the animal models used to study the in vivo properties of melanoma cells.lld:pubmed
pubmed-article:8146087pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8146087pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8146087pubmed:languageenglld:pubmed
pubmed-article:8146087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8146087pubmed:citationSubsetIMlld:pubmed
pubmed-article:8146087pubmed:statusMEDLINElld:pubmed
pubmed-article:8146087pubmed:monthDeclld:pubmed
pubmed-article:8146087pubmed:issn0893-5785lld:pubmed
pubmed-article:8146087pubmed:authorpubmed-author:FerroneSSlld:pubmed
pubmed-article:8146087pubmed:authorpubmed-author:ByersR HRHlld:pubmed
pubmed-article:8146087pubmed:authorpubmed-author:Gattoni-Celli...lld:pubmed
pubmed-article:8146087pubmed:authorpubmed-author:CaloriniLLlld:pubmed
pubmed-article:8146087pubmed:issnTypePrintlld:pubmed
pubmed-article:8146087pubmed:volume6lld:pubmed
pubmed-article:8146087pubmed:ownerNLMlld:pubmed
pubmed-article:8146087pubmed:authorsCompleteYlld:pubmed
pubmed-article:8146087pubmed:pagination381-4lld:pubmed
pubmed-article:8146087pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:meshHeadingpubmed-meshheading:8146087-...lld:pubmed
pubmed-article:8146087pubmed:year1993lld:pubmed
pubmed-article:8146087pubmed:articleTitleOrgan-specific metastases in melanoma: experimental animal models.lld:pubmed
pubmed-article:8146087pubmed:affiliationDepartment of Radiation Oncology, New England Medical Center Hospitals, Boston, Massachusetts 02111.lld:pubmed
pubmed-article:8146087pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8146087pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8146087pubmed:publicationTypeReviewlld:pubmed